Rose Ann Ferre

6.5k citations

29 papers · 2.3k indexed · 2 hit papers · h-index 22

Molecular Biology top 10%
Cardiology and Cardiovascular Medicine top 5%
Infectious Diseases top 5%
Oncology top 5%
Organic Chemistry top 5%

Co-authors: David A. Matthews Stephen T. Worland Shella A. Fuhrman Amy K. Patick James W. Meador Peter S. Dragovich Edward L. Brown Brion W. Murray
Topics: Viral Infections and Immunology Research (11 papers)RNA and protein synthesis mechanisms (5 papers)Peptidase Inhibition and Analysis (4 papers)
Cited by: Infectious Diseases Cardiology and Cardiovascular Medicine Oncology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Canada China

In The Last Decade

Rose Ann Ferre

29 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

2016 307 citations Ping Chen, Nathan V. Lee et al. Molecular Cancer Therapeutics profile →
Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

2022 114 citations S.E. Greasley, Stephen Noell et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Rose Ann Ferre

Since Specialization

Citations

This map shows the geographic impact of Rose Ann Ferre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Ann Ferre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Ann Ferre more than expected).

Fields of papers citing papers by Rose Ann Ferre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Ann Ferre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Ann Ferre. The network helps show where Rose Ann Ferre may publish in the future.

Co-authorship network of co-authors of Rose Ann Ferre

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Ann Ferre. A scholar is included among the top collaborators of Rose Ann Ferre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Ann Ferre. Rose Ann Ferre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of the substrate preference of a MYST acetyltransferase by a scaffold protein 2025 ·Journal of Biological Chemistry ·(unknown),Oleg Brodsky,Patrick Bingham,Wade Diehl,Rose Ann Ferre,S.E. Greasley,Eric F. Johnson,Michelle L. Kraus,(unknown),Jordan L. Meier,Thomas A. Paul,Karen A. Maegley	1
2	Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variantsbreakdown → 2022 ·Journal of Biological Chemistry ·S.E. Greasley,Stephen Noell,Olga Plotnikova,Rose Ann Ferre,(unknown),Ben Bolaños,Kimberly F. Fennell,(unknown),Timothy K. Craig,(unknown),Al Stewart,Claire M. Steppan	114
3	The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase 2017 ·Journal of Biological Chemistry ·K.S. Gajiwala,Neil B. Grodsky,Ben Bolaños,Junli Feng,Rose Ann Ferre,Sergei Timofeevski,Meirong Xu,Brion W. Murray,Ted W. Johnson,Al Stewart	41
4	Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors 2017 ·Cell chemical biology ·Sherry Niessen,Melissa M. Dix,(unknown),Zachary E. Potter,Shuyan Lu,Oleg Brodsky,Simon Planken,Douglas C. Behenna,Chau Almaden,K.S. Gajiwala,Kevin Ryan,Rose Ann Ferre,Michael R. Lazear,Matthew M. Hayward,John C. Kath,Benjamin F. Cravatt	77
5	Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performancebreakdown → 2016 ·Molecular Cancer Therapeutics ·Ping Chen,Nathan V. Lee,Wenyue Hu,Meirong Xu,Rose Ann Ferre,Hieu Lam,Simon Bergqvist,James Solowiej,Wade Diehl,You-Ai He,Xiu Yu,Asako Nagata,Todd VanArsdale,Brion W. Murray	307
6	Ack1: Activation and Regulation by Allostery 2013 ·PLoS ONE ·K.S. Gajiwala,Karen A. Maegley,Rose Ann Ferre,You-Ai He,Xiu Yu	21
7	Insights into the Aberrant Activity of Mutant EGFR Kinase Domain and Drug Recognition 2012 ·Structure ·K.S. Gajiwala,Junli Feng,Rose Ann Ferre,Kevin Ryan,Oleg Brodsky,Scott L. Weinrich,John C. Kath,Al Stewart	140
8	Novel isoquinolone PDK1 inhibitors discovered through fragment-based lead discovery 2011 ·Journal of Computer-Aided Molecular Design ·M. Catherine Johnson,Qiyue Hu,Laura Lingardo,Rose Ann Ferre,S.E. Greasley,Jiangli Yan,John C. Kath,Ping Chen,Jacques Ermolieff,Gordon Alton	15
9	Structure-based design of novel human Pin1 inhibitors (II) 2010 ·Bioorganic & Medicinal Chemistry Letters ·Liming Dong,Joseph Marakovits,Xinjun Hou,Chuangxing Guo,S.E. Greasley,Eleanor Dagostino,Rose Ann Ferre,M. Catherine Johnson,Eugenia Kraynov,James Thomson,(unknown),Brion W. Murray	70
10	Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation 2010 ·Bioorganic & Medicinal Chemistry ·William F. Vernier,Wesley K. M. Chong,David A. Rewolinski,S.E. Greasley,Thomas Pauly,(unknown),Dac M. Dinh,Rose Ann Ferre,Seiji Nukui,Martha A. Ornelas,Eric L. Reyner	39
11	Structure-based design of novel human Pin1 inhibitors (I) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo,Xinjun Hou,Liming Dong,Eleanor Dagostino,S.E. Greasley,Rose Ann Ferre,Joseph Marakovits,M. Catherine Johnson,David A. Matthews,Barbara Mroczkowski,Hans E. Parge,Todd VanArsdale,Ian Popoff,Joseph Piraino,Stephen A. Margosiak,James Thomson,Gerrit Los,Brion W. Murray	91
12	AG-024322 is a potent and selective multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity 2005 ·Cancer Research ·Cathy C. Zhang,Susan E. Kephart,Indrawan McAlpine,Jim Nonomiya,Joseph R. Higgins,Maria E. Arango,Zhengming Yan,(unknown),Rose Ann Ferre,Jayashree Tikhe,Gennady M. Verkhivker,Meirong Xu,(unknown),Cindy Palmer,Julie Park,Siegfried Reich,(unknown),Lin Li,Gerrit Los,Cristina Lewis	8
13	The Crystal Structure of the RNA-Dependent RNA Polymerase from Human Rhinovirus 2004 ·Structure ·Robert A. Love,Karen A. Maegley,Xiu Yu,Rose Ann Ferre,Laura Lingardo,Wade Diehl,Hans E. Parge,Peter S. Dragovich,Shella A. Fuhrman	87
14	Structure of pteridine reductase (PTR1) fromLeishmania tarentolae 2003 ·Acta Crystallographica Section D Biological Crystallography ·Haiyan Zhao,(unknown),Marc Ouellette,Ming Zhao,Rose Ann Ferre,David A. Matthews,John M. Whiteley,Kottayil I. Varughese	14
15	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics 2002 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich,Thomas J. Prins,Ru Zhou,Theodore Johnson,Edward L. Brown,(unknown),Shella A. Fuhrman,L S Zalman,Amy K. Patick,David A. Matthews,Xinjun Hou,James W. Meador,Rose Ann Ferre,Stephen T. Worland	63
16	Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Stephen E. Webber,Joseph Marakovits,Peter S. Dragovich,Thomas J. Prins,Ru Zhou,Shella A. Fuhrman,Amy K. Patick,David A. Matthews,Caroline A. Lee,Srinivasan Babu,(unknown),Clifford E. Ford,Mary A. Brothers,(unknown),James W. Meador,Rose Ann Ferre,Stephen T. Worland	10
17	Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids 1999 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich,Stephen E. Webber,Thomas J. Prins,Ru Zhou,Joseph Marakovits,Jayashree Tikhe,Shella A. Fuhrman,Amy K. Patick,David A. Matthews,Clifford E. Ford,Edward L. Brown,Susan L. Binford,James W. Meador,Rose Ann Ferre,Stephen T. Worland	18
18	Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes 1999 ·Proceedings of the National Academy of Sciences ·David A. Matthews,Peter S. Dragovich,S. E. Webber,Shella A. Fuhrman,Amy K. Patick,L S Zalman,Thomas F. Hendrickson,Robert A. Love,Thomas J. Prins,Joseph Marakovits,Ru Zhou,Jayashree Tikhe,C. E. Ford,James W. Meador,Rose Ann Ferre,Edward L. Brown,Susan L. Binford,M. A. Brothers,Dorothy M. DeLisle,Stephen T. Worland	243
19	Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein 1994 ·Cell ·David A. Matthews,Ward W. Smith,Rose Ann Ferre,(unknown),(unknown),(unknown),J. Ernest Villafranca,Cheryl A. Janson,(unknown),(unknown),Stephen T. Worland	285
20	2.3 Å crystal structure of the catalytic domain of DNA polymerase β 1994 ·Cell ·Jay F. Davies,Robert J. Almassy,Zuzana Hostomska,Rose Ann Ferre,Zdeněk Hostomský	152

About Rose Ann Ferre

Rose Ann Ferre is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics, having authored 29 papers that have together received 2.3k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (11 papers), RNA and protein synthesis mechanisms (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Infectious Diseases (534 citations), Cardiology and Cardiovascular Medicine (574 citations) and Oncology (519 citations). Rose Ann Ferre has collaborated with scholars based in United States, Canada and China. Frequent co-authors include David A. Matthews, Stephen T. Worland, Shella A. Fuhrman, Amy K. Patick, James W. Meador, Peter S. Dragovich, Edward L. Brown, Brion W. Murray, Thomas F. Hendrickson and Xiu Yu. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact